Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. [electronic resource]
Producer: 19990610Description: 334-42 p. digitalISSN:- 0033-3158
- Aged
- Alzheimer Disease -- drug therapy
- Cognition -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Hydrocortisone -- blood
- Isoxazoles -- blood
- Learning -- drug effects
- Male
- Memory -- drug effects
- Middle Aged
- Nicotinic Agonists -- pharmacology
- Prolactin -- blood
- Psychomotor Performance -- drug effects
- Pyrrolidines -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.